Elosulfase alfa for treating mucopolysaccharidosis type 4A

Equality Impact Assessment (Guidance development) (PDF 162 KB)

Final evaluation determination

Public committee slides (PDF 1.02 MB)

Committee papers (PDF 3.88 MB)

Final evaluation determination document (PDF 324 KB)

Evaluation consultation

Evaluation consultation document (PDF 321 KB)

Public committee slides (PDF 1.47 MB)

Committee papers (PDF 8.66 MB)

Evaluation consultation document (Online commenting)

Final scope (PDF 167 KB)

Final stakeholder list (PDF 185 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 460 KB)

Equality Impact Assessment (Guidance development) (PDF 131 KB)

Draft matrix post referral (PDF 185 KB)

Draft scope post referral (PDF 173 KB)